Protecting infants born to people with HIV from serious infections

Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections

NIH-funded research University of Colorado Denver · NIH-11389012

Looking at whether differences in gut bacteria and their products can help prevent serious infections in babies born to people with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-11389012 on NIH RePORTER

What this research studies

You or your baby would be part of a comparison between infants exposed to HIV but uninfected (HEU) and infants not exposed to HIV (HU). The team will collect blood and stool at about 6, 24, and 48 weeks to measure immune cells, gene activity, DNA changes, blood metabolites, and gut bacteria using 16S sequencing. They will link specific bacterial types and metabolites to immune problems seen in HEU infants and test those links in the lab. The ultimate goal is to see whether diet or other ways of changing the gut microbes could boost infant immunity.

Who could benefit from this research

Good fit: Ideal candidates are HIV-exposed but uninfected infants in their first year of life, with a comparison group of HIV-unexposed infants of similar age.

Not a fit: HIV-positive infants, older children, or adults would not be eligible and are unlikely to benefit directly from this infant-focused work.

Why it matters

Potential benefit: Could lead to diet- or microbiome-based approaches to boost immunity and reduce serious infections in HIV-exposed uninfected infants.

How similar studies have performed: Prior research has found immune and microbiome differences in HEU infants, but using microbiome- or diet-based interventions to prevent infections is still largely experimental.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.